Aldeyra Therapeutics Inc (ALDX)
4.81
+0.05
(+1.05%)
USD |
NASDAQ |
Nov 21, 16:00
4.82
+0.01
(+0.21%)
After-Hours: 20:00
Aldeyra Therapeutics Enterprise Value: 185.99M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 185.99M |
| November 19, 2024 | 196.71M |
| November 18, 2024 | 182.42M |
| November 15, 2024 | 153.24M |
| November 14, 2024 | 156.81M |
| November 13, 2024 | 165.15M |
| November 12, 2024 | 185.69M |
| November 11, 2024 | 229.46M |
| November 08, 2024 | 231.25M |
| November 07, 2024 | 220.53M |
| November 06, 2024 | 224.10M |
| November 05, 2024 | 216.36M |
| November 04, 2024 | 211.00M |
| November 01, 2024 | 221.72M |
| October 31, 2024 | 215.77M |
| October 30, 2024 | 220.53M |
| October 29, 2024 | 225.29M |
| October 28, 2024 | 237.20M |
| October 25, 2024 | 219.64M |
| October 24, 2024 | 222.61M |
| October 23, 2024 | 230.06M |
| October 22, 2024 | 253.88M |
| October 21, 2024 | 231.84M |
| October 18, 2024 | 241.97M |
| October 17, 2024 | 233.04M |
| Date | Value |
|---|---|
| October 16, 2024 | 233.63M |
| October 15, 2024 | 221.72M |
| October 14, 2024 | 226.49M |
| October 11, 2024 | 222.32M |
| October 10, 2024 | 219.34M |
| October 09, 2024 | 213.38M |
| October 08, 2024 | 215.17M |
| October 07, 2024 | 216.96M |
| October 04, 2024 | 220.53M |
| October 03, 2024 | 213.98M |
| October 02, 2024 | 218.15M |
| October 01, 2024 | 217.55M |
| September 30, 2024 | 223.51M |
| September 27, 2024 | 221.73M |
| September 26, 2024 | 214.00M |
| September 25, 2024 | 215.79M |
| September 24, 2024 | 230.64M |
| September 23, 2024 | 226.48M |
| September 20, 2024 | 244.90M |
| September 19, 2024 | 253.82M |
| September 18, 2024 | 243.72M |
| September 17, 2024 | 238.37M |
| September 16, 2024 | 246.09M |
| September 13, 2024 | 253.22M |
| September 12, 2024 | 262.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-59.61M
Minimum
May 12 2022
624.27M
Maximum
Jun 08 2021
197.22M
Average
188.48M
Median
Nov 11 2020
Enterprise Value Benchmarks
| AbbVie Inc | 360.29B |
| NovaBay Pharmaceuticals Inc | 2.745M |
| Palatin Technologies Inc | 15.49M |
| iBio Inc | 9.932M |
| Theriva Biologics Inc | -12.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.11M |
| Total Expenses (Quarterly) | 16.14M |
| EPS Diluted (Quarterly) | -0.25 |
| Earnings Yield | -15.56% |